PRESS RELEASE published on 06/03/2024 at 07:30, 3 months 16 days ago Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la tête et du cou Transgene annonce l'inclusion du premier patient dans la partie Phase II de l'étude randomisée de Phase I/II pour son vaccin TG4050 dans les cancers de la tête et du cou. Démarrage de la sélection des patients pour cette étude internationale Cancer De La Tête Et Du Cou Étude Clinique Transgene Vaccin Thérapeutique Néoantigènes
BRIEF published on 05/14/2024 at 17:50, 4 months 5 days ago Transgene Announces Positive Q1 2024 Update and Future Clinical Milestones Clinical Trials Financial Update Cancer Immunotherapy Transgene TG4050
BRIEF published on 05/14/2024 at 17:50, 4 months 5 days ago Transgene annonce une mise à jour positive pour le premier trimestre 2024 et de futures étapes cliniques Essais Cliniques Mise À Jour Financière Immunothérapie Anticancéreuse Transgene TG4050
PRESS RELEASE published on 05/14/2024 at 17:45, 4 months 5 days ago Transgene fait le point sur ses activités et sa situation financière au premier trimestre 2024 Point sur les activités et la situation financière de Transgene au premier trimestre 2024, avec des données prometteuses de Phase I pour TG4050 et des prévisions de nouvelles données cliniques pour TG4001, TG6050 et BT-001 Biotechnologie Santé Financière Immunothérapie Transgene TG4050
PRESS RELEASE published on 05/14/2024 at 17:45, 4 months 5 days ago Transgene provides business and financial update for Q1 2024 Transgene provides business and financial update for Q1 2024, including promising Phase I data on TG4050 and upcoming clinical data expectations on TG4001, TG6050, and BT-001 in H2 2024 Clinical Data Q1 2024 Financial Update Transgene TG4050
Published on 09/19/2024 at 17:30, 1 hour 17 minutes ago Airborne Geophysical Survey Completed at Pine Channel Gold Project, Saskatchewan
Published on 09/19/2024 at 17:00, 1 hour 47 minutes ago Cypress Creek Consulting Advises Charter Communications on Inaugural Securitization Financing Facility
Published on 09/19/2024 at 15:45, 3 hours 2 minutes ago eLearners Make eLearning a Daily or Weekly Habit, Voices' eLearning Report Finds
Published on 09/19/2024 at 15:20, 3 hours 27 minutes ago Taurus secures "Best Digital Assets Solution" at 2024 Global BankTech Awards
Published on 09/19/2024 at 15:01, 3 hours 46 minutes ago ful. CashPay: Revolutionizing Healthcare Access for Employers With Uninsured Team Members
Published on 09/19/2024 at 17:52, 54 minutes ago PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Published on 09/19/2024 at 17:52, 54 minutes ago PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Published on 09/19/2024 at 17:52, 55 minutes ago EQS-Adhoc: SMT Scharf AG: New CEO joins the Managing Board
Published on 09/19/2024 at 17:45, 1 hour 2 minutes ago AFG Holding SA acquiert une participation majoritaire dans le groupe allemand Access Holding et prend ainsi le contrôle de
Published on 09/19/2024 at 17:45, 1 hour 2 minutes ago Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Published on 09/19/2024 at 17:45, 1 hour 2 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Published on 09/19/2024 at 17:45, 1 hour 2 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)